Application Features Sample Clauses

Application Features. Without limiting the foregoing, the Application Process will include (in each case, to Amazon Services’ reasonable satisfaction) (1) [***]; (2) with respect to Program Application that relates to applying for Program Credit, (A) a credit decision and real-time notification for Program Applications subject to the Performance Standards set forth in Schedule 4.1; (B) immediate access to approved Program Credit to purchase a Basket on or through any Participating Site; (C) application requirements that are required under Applicable Law; and (D) real-time identification of the applicant to comply with Applicable Law.
Sample 1
AutoNDA by SimpleDocs
Application Features. 4.1. Digital Turbine shall host the Digital Turbine Server in the United States.
Sample 1
Application Features. The historical data archive is a web-based module which provides menu driven access to a series of screens and reports designed for user access. The web front end is very similar in nature to the inquiry options within Munis to provide users with a familiar and intuitive interface. The screens provide the ability to perform advanced searches and return data which may then be viewed and exported to Excel, if needed. The following screens will be available within the historical archive database. Information on these screens will correlate with the Munis screens whenever possible; however, certain pieces of information which would become stale over time are omitted. All data available through the Munis Conversion programs have the opportunity for inclusion in the data archive. Screen Content Accounts, Project Central All related financial activity for a given Xxxxx XX Organization, Object and Project including budget, actual and encumbrance data. Vendor Central All related financial activity for a vendor, and drill down into the detail in: Checks, Invoices, Purchase Order, Contracts. Purchasing Central Purchase order and line item detail with associated AP Invoices. Contracts Central Contract information with associated AP Invoices and Purchase Orders. Invoice Central AP Invoice information with associated purchase orders and payment details. Check History Employee payroll check history Employee Job/Salary Employee job and salary history Employee Deductions Employee payroll deductions Employee Master Employee tracking and general information Deliverables The following deliverables will be provided with the solution: • Web based application to access historical data • Training to use the historical data application • KHC will assist client in converting and populating data input spreadsheets to match mapping requirements • Data conversion templates for mapping o KHC will use the same mapping spreadsheets as the Munis Data Conversion Team • Historical data will be converted into the archival database using the Munis data structure Client Responsibilities • Client shall provide access to fulfill the necessary requirements to historical data files, data mapping expertise and any other necessary information to facilitate the archival process • Client shall furnish legacy system documentation for data mapping, as needed • Client shall furnish the required hardware to run the archival system unless the client chooses the SaaS option • Client shall provide necessary ...
Sample 1
Application Features. Requirements for innovative services that do not directly affect the user profile, but contribute to improving the user experience of applications related to the CPN platform. For example: ➔ Bursting ‘Filter Bubbles’ ➔ Avoiding Fear of missing out (FOMO) ➔ Transparency of how user profile data is used for personalization ➔ ...
Sample 1
Application Features. 9.1 Home On your Home screen, you will access to your 15 latest transactions.
Sample 1
Application Features 
Sample 1Sample 2

Related to Application Features

  • Application of Collections On each Payment Date, all collections for the related Collection Period shall be applied by the Servicer as follows:

  • Application of Net Proceeds The Company shall apply the net proceeds from the Offering received by it in a manner consistent with the application thereof described under the caption “Use of Proceeds” in the Registration Statement, the Pricing Disclosure Package and the Prospectus.

  • Application Notwithstanding anything to the contrary contained in this Agreement, Cash Collateral provided under any of this Section 2.14 or Sections 2.03, 2.05, 2.15 or 8.02 in respect of Letters of Credit shall be held and applied to the satisfaction of the specific L/C Obligations, obligations to fund participations therein (including, as to Cash Collateral provided by a Revolving Lender that is a Defaulting Lender, any interest accrued on such obligation) and other obligations for which the Cash Collateral was so provided, prior to any other application of such property as may be provided for herein.

  • Publicity/Use of Names Neither Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior express written permission of the other Party, except for those disclosures expressly authorized under this Article 4. Following execution of this Agreement, either Party may issue a press release announcing the existence of this Agreement in form and substance agreed to in writing by both Parties, such agreement to not be unreasonably withheld or delayed. Each Party agrees not to issue any other press release or other public statement disclosing other information relating to this Agreement or the transactions contemplated hereby without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed; provided that Arvinas agrees that it shall be deemed reasonable for Pfizer to withhold its consent for the disclosure of any information related to a Target or a specific Compound or the amount of any payment made or to be made under this Agreement; and provided further that any disclosure which is required by Law or the rules of a securities exchange, as reasonably advised by the disclosing Party’s counsel, may be made subject to the following. Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release. Except under extraordinary circumstances or to the extent any such advance notice or notice period is not consistent with applicable Law, each Party shall provide the other with an advance copy of any such announcement at least [**] prior to its scheduled release. Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by Law, the Party whose announcement has been reviewed shall remove any information the reviewing Party reasonably deems to be inappropriate for disclosure. The contents of any announcement or similar publicity which has been reviewed and approved by the reviewing Party can be re-released by either Party without a requirement for re-approval. In addition, except to the extent required by Laws in connection with patent enforcement activities conducted in accordance with Article 7, Pfizer shall not use the name “Yale” or “Yale University,” nor any variation or adaptation thereof, nor any trademark, trade name or other designation owned by Yale University, nor the names of any of its trustees, officers, faculty, students, employees or agents, for any purpose without the prior written consent of Yale University in each instance, such consent to be granted or withheld by Yale University in its sole discretion, except that Pfizer may state that it has sublicensed from Yale University one or more of the patents or applications comprising the Yale Licensed Patents.

  • Patent Listings Licensee shall have the right and responsibility to make all filings with Regulatory Authorities in the Territory with respect to the AstraZeneca Patents, including as required or allowed (i) in the United States, in the FDA’s Orange Book and (ii) in the European Union, under the national implementations of Article 10.1(a)(iii) of Directive 2001/EC/83 or other international equivalents; provided that Licensee shall consult with AstraZeneca to determine the course of action with respect to such filings.

  • Application of Agreement 4.1 This Agreement applies to:

Time is Money Join Law Insider Premium to draft better contracts faster.